depression fda - Search News

FDA approves Johnson & Johnson’s nasal spray for depression

Newsweek on MSN · 3h

FDA Approves Nasal Spray for Depression

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants.

CNN on MSN · 13h

FDA approves standalone use of J&J’s ketamine-derived depression treatment

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.

UPI News on MSN · 8h

FDA approves Spravato, first monotherapy nasal spray to treat depression

The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato was approved to treat a major depressive disorder,

1h

J&J’s Spravato receives FDA label expansion for depression monotherapy

Johnson & Johnson’s (J&J) nasal spray Spravato (esketamine) has received a label expansion, now approved as a monotherapy ...

9hon MSN

Why a common asthma drug will now carry extra safety warnings about depression

The TGA has issued a requirement for new warnings to be provided with the drug montelukast, commonly used to treat asthma and ...

3don MSN

Research indicates recreational ketamine use is on the rise

Respondents who said they used other drugs recreationally were also likelier to say they used ketamine during the past year ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results